From: An assessment of the vaccination of school-aged children in England against SARS-CoV-2
Protection against: | AstraZeneca | Pfizer | ||
---|---|---|---|---|
 | Dose 1 | Dose 2 | Dose 1 | Dose 2 |
Infection | 45% | 70% | 55% | 85% |
Symptoms | 45% | 70% | 55% | 90% |
Hospitalisation | 80% | 95% | 80% | 95% |
Deaths | 80% | 98% | 80% | 98% |